Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Agora

Re: Agora

in response to by
posted on Jun 13, 2008 07:54AM

Good Afternoon Albie and dear PTSC Shareholders and Community Members.

Thank you for your message and for bringing this issue to our attention. Keeping a balance between objectivity, relevance and community wellness is quite hard to strike. Removing all the messages which add little or nothing to a company would detriment free expression; allowing everything to remain posted would equate to chaos.

So we apply a balance of the above. Our six rules of use are clear and while not as thorough as a 20 page document outlining posting behaviour and criteria have proven to work for the benefit of all members within our community.

We would like to once again stress that we are not here to police anyone; we encourage the free exchange of opinions, expressions and view on any main discussion board provided those are backed up by fact. In the cases were an opinion is unsubstantiated or cannot be reasoned with it is removed. Otherwise it is acceptable.

Relevance is a vague principle and one which varies from individual to individual. Please take that into consideration when viewing a message on our boards. What is irrelevant or obsolete now was indeed a fellow community member’s expression three hours ago, and it was backed up by fact.

AGORACOM must react to any and every situation of relevance or reviewing a violation; and in an attempt to keep our community clean our admins try their hardest not to side or show any inclination of favouritism when tackling any issue. By not reacting we are guilty of apathy. By reacting we run the risk of all sorts of labels. However we firmly believe that we have achieved a balance between these sides.

Thank you again for your message and for your contributions within the AGORACOM community.

Regards,

AGORACOM









Share
New Message
Please login to post a reply